EXHIBIT 4.7 WARRANT AGREEMENT AGREEMENT, dated as of this 23rd day of August, 1996, by and among Sparta Pharmaceuticals, Inc., a Delaware corporation ("Company"), Midlantic National Bank, as Warrant Agent (the "Warrant Agent"), and Paramount Capital,...Warrant Agreement • October 17th, 1996 • Sparta Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
Employee Copy _________ Company Copy _________ Option Number _________ SPARTA PHARMACEUTICALS, INC. INCENTIVE STOCK OPTION AGREEMENT AGREEMENT made as of the 15th day of March, 1996, between Sparta Pharmaceuticals, Inc. (the "Company"), a Delaware...Incentive Stock Option Agreement • March 27th, 1997 • Sparta Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Pennsylvania
Exhibit 10.101 SPARTA PHARMACEUTICALS, INC. NONQUALIFIED STOCK OPTION AGREEMENT AGREEMENT made as of the __th day of ___, 199_, between Sparta Pharmaceuticals, Inc. (the "Company"), a Delaware corporation having a principal place of business at 111...Nonqualified Stock Option Agreement • May 15th, 1998 • Sparta Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
NEITHER THESE SECURITIES NOR THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN...Sparta Pharmaceuticals Inc • March 23rd, 1998 • Biological products, (no disgnostic substances) • Delaware
LICENSE AGREEMENT This Agreement is effective December 4, 1997 ("the EFFECTIVE DATE") by and between Estate of Karl H. Beyer, Jr. ("LICENSOR"), having an address c/o George Q. Hardwick, Esq., 506 Spring House Village Center, Spring House, PA 19477,...License Agreement • March 23rd, 1998 • Sparta Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
EXHIBIT 10.95 ------------- SPARTA PHARMACEUTICALS, INC. STOCK OPTION AGREEMENT This certifies that, pursuant to the Sparta Pharmaceuticals, Inc. 1991 Stock Plan, as amended, the Board of Directors of Sparta Pharmaceuticals, Inc. has granted an option...Stock Option Agreement • November 7th, 1997 • Sparta Pharmaceuticals Inc • Biological products, (no disgnostic substances)
Exhibit 10.103 EXCLUSIVE LICENSE AGREEMENT by and between SPARTA PHARMACEUTICALS, INC.Exclusive License Agreement • May 15th, 1998 • Sparta Pharmaceuticals Inc • Biological products, (no disgnostic substances)
SPARTA PHARMACEUTICALS, INC. STOCK OPTION AGREEMENT This certifies that, pursuant to the Sparta Pharmaceuticals, Inc. 1991 Stock Plan, as amended, the Board of Directors of Sparta Pharmaceuticals, Inc. has granted an option to purchase shares of...Stock Option Agreement • March 27th, 1997 • Sparta Pharmaceuticals Inc • Biological products, (no disgnostic substances)
AMENDED AND RESTATED SUBLICENSE AGREEMENT THIS AGREEMENT is made this the first day of January, 1997 by and between Research Triangle Pharmaceuticals Ltd., a North Carolina corporation which has its principal place of business at 4364 S. Alston...Sublicense Agreement • March 27th, 1997 • Sparta Pharmaceuticals Inc • Biological products, (no disgnostic substances) • North Carolina
NET LEASE AGREEMENTEscrow Agreement • March 27th, 1997 • Sparta Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Pennsylvania
EXHIBIT 10.96 -------------Stock Option Agreement • March 23rd, 1998 • Sparta Pharmaceuticals Inc • Biological products, (no disgnostic substances)
BY AND AMONGAgreement and Plan of Reorganization • January 20th, 1999 • Sparta Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
AMENDMENT TO OPTION AGREEMENT and OPTION AGREEMENT dated as of June 17, 1996 by and between SPARTA PHARMACEUTICALS, INC., with offices at Pennsylvania Business Campus, 111 Rock Road, Horsham, PA 19044, a Delaware corporation (the "Company") and...Option Agreement and Option Agreement • March 27th, 1997 • Sparta Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
